GRP
KERX

Global Retirement Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Global Retirement Partners’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-240
Closed -$1K – 1597
2018
Q1 		$1K Hold
240
– – ﹤0.01% 1469
2017
Q4 		$1K Buy
+240
New +$1.32K ﹤0.01% 1418

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global Retirement Partners's KERX Position: Q2 2018 in Review

Global Retirement Partners sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2018, closing a stake of 240 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in KERX in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2018. 132 funds tracked by Wall St. Rank hold KERX as of Q2 2018.

  • Global Retirement Partners reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
  • Global Retirement Partners sold 240 Keryx Biopharmaceuticals Inc shares in Q2 2018, an estimated $1K.
  • Global Retirement Partners first reported a position in Keryx Biopharmaceuticals Inc in Q4 2017 and held it in 2 quarters.
  • Global Retirement Partners's Keryx Biopharmaceuticals Inc position peaked at $1K in Q1 2018.
  • 132 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2018.

Based on Global Retirement Partners's 13F filing for Q2 2018, filed 13 Aug 2018.